Primus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPrimus Pharmaceuticals

Primus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Impoyz	Clobetasol	2017-11-28	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Metaxalone	Metaxalone	2015-06-01	2026	Myositis , Pain , Muscle spasticity , Muscle cramp , Spasm , Muscle rigidity
Sernivo	Betamethasone	2016-02-05	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

pathologic constriction

,

spinal stenosis

,

,

cognitive dysfunction

,

,

healthy volunteers/patients

healthy volunteers/patients

Clobetasol propionate

healthy volunteers/patients

Betamethasone dipropionate

healthy volunteers/patients

,

,

,

skin and connective tissue diseases

,

connective tissue diseases

,

,

atopic dermatitis

,

,

insulin resistance

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

,

type 2 diabetes mellitus

,

,

systemic scleroderma

,

diffuse scleroderma

,

acute radiation syndrome

,

healthy volunteers/patients

,

,

,

acquired immunodeficiency syndrome

,

,

cutaneous malignant melanoma

,

head and neck neoplasms

,

radiation injuries

,

endometrial neoplasms

,

precursor cell lymphoblastic leukemia-lymphoma

,

breast neoplasms

,

,

non-small-cell lung carcinoma

,

,

pancreatic neoplasms

,

,

lymphoid leukemia

,

,

non-hodgkin lymphoma

,

,

cystic fibrosis

,

neoplasm metastasis

,

renal cell carcinoma

,

,

kidney neoplasms

,

,

urinary bladder neoplasms

,

,

atherosclerosis

,

,

b-cell chronic lymphocytic leukemia

,

,

brain neoplasms

,

,

,

hodgkin disease

,

germ cell and embryonal neoplasms

,

medulloblastoma

,

,

rhabdomyosarcoma

,

primitive neuroectodermal tumors

,

,

colorectal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

endometrial hyperplasia

,

,

vitamin a deficiency

,

night blindness

,

,

ocular hypertension

,

,

,

pulmonary fibrosis

,

,

small cell lung carcinoma

,

major depressive disorder

,

depressive disorder

,

coronary disease

,

myocardial ischemia

,

,

,

,

metabolic brain diseases

,

respiratory sounds

,

,

,

familial amyloid neuropathies

,

interstitial lung diseases

,

prostatic neoplasms

,

,

,

metabolic bone diseases

,

metabolic syndrome

,

glucose intolerance

,

,

,

,

coronary artery disease

,

cardiovascular diseases

,

,

post-acute covid-19 syndrome

,

irritable bowel syndrome

,

,

pelvic floor disorders

,

,

,

,

type 2 diabetes mellitus

,

alzheimer disease

,

squamous cell carcinoma of head and neck

,

,

insulin resistance

,

,

,

male breast neoplasms

,

disease progression

,

,

nutrition therapy

,

hereditary breast and ovarian cancer syndrome

,

,

,

muscle spasticity

,

,

,

prediabetic state

,

metabolic diseases

,

nutritional and metabolic diseases

,

,

non-alcoholic fatty liver disease

,

,

,

cardiomyopathies

,

genetic predisposition to disease

,

myocardial infarction

,

hyperlipidemias

,

hematologic neoplasms

,

neurotoxicity syndromes

,

,

cognitive dysfunction

,

pudendal neuralgia

,

,

non-muscle invasive bladder neoplasms

,

,

,

,

knee osteoarthritis

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use